1-3 of 3
Xue Sun
Close
Sort by
Journal Articles

A novel RIPK1 inhibitor reduces GVHD in mice via a nonimmunosuppressive mechanism that restores intestinal homeostasis

Xiaoliang Yu, Haikuo Ma, Bohan Li, Yuting Ji, Yayun Du, Siying Liu, Zhanhui Li, Yongjin Hao, Sheng Tian, Cong Zhao, Qian Du, Zhongqin Jin, Xueming Zhu, Yuanyuan Tian, Xin Chen, Xue Sun, Chengkui Yang, Fang Zhu, Jie Ju, Yunjing Zheng, Wei Zhang, Jingrui Wang, Tao Yang, Xinhui Wang, Jingjing Li, Xiangping Xu, Shujing Du, Haohao Lu, Feng Ma, Haibing Zhang, Yi Zhang, Xiaohu Zhang, Shaoyan Hu, Sudan He
Journal: Blood
Blood (2023) 141 (9): 1070–1086.
https://doi.org/10.1182/blood.2022017262
Published: 2023
Includes: Supplemental data
Journal Articles

Effect of MRD Level after Induction Therapy and Post-Remission Treatment on Prognosis of ALL Patients

Xue Sun, Xiaosheng Fang, Xiaoqian Liu, Ying Li, Xue Shi, Yahan Li, Ran Tan, Yujie Jiang, Xiaohui Sui, Xueling Ge, Hongzhi Xu, Xin Wang
Journal: Blood
Blood (2022) 140 (Supplement 1): 11850–11851.
https://doi.org/10.1182/blood-2022-168452
Published: 2022
Journal Articles

Combination of NCCN Risk Stratification System and Pre-Transplant Minimal Residual Disease Levels for the Prognosis of Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation

Yahan Li, Xue Sun, Xin Wang, Xiaosheng Fang
Journal: Blood
Blood (2021) 138 (Supplement 1): 3434.
https://doi.org/10.1182/blood-2021-149479
Published: 2021